China Reform Securities logo

China Reform Securities

Asia, Beijing, China, Beijing

Description

China Reform Securities is a private equity investment fund.

Investor Profile

China Reform Securities has made 7 investments, with 6 in the past 12 months and 43% as lead.

Stage Focus

  • Series A (43%)
  • Series B (43%)
  • Series Unknown (14%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Software
  • Robotics
  • Sales
  • Agriculture
  • Agtech
  • Forestry
  • Construction
  • Intelligent Systems
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Reform Securities frequently co-invest with?

Cowin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Co-Investments: 1
Hefei Industry Investment Group
Asia, Anhui, China, Hefei
Co-Investments: 1
Wofo Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Walden International
North America, California, United States, San Francisco
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
PC
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by China Reform Securities?

Shudun Technology

Beijing, Beijing, China

Shudun is a leading technology company in China.

Consumer ElectronicsEnergyHardwareInformation TechnologySoftware
Series UnknownFeb 17, 2025
Sinsegye

Nanshan, Hunan, China

Sinsegye operates as a product-driven enterprise company.

Industrial AutomationSoftware
Series BJan 24, 2025
Amount Raised: $27,608,675
EllipSpace

Beijing, Beijing, China

EllipSpace provides real-time remote sensing and navigation enhancement integrated services.

AerospaceInternet of ThingsRemote SensingSatellite Communication
Series BJan 10, 2025
Excell

Huzhou, Zhejiang, China

Excell is an intelligent technology company that provides smart city construction solutions.

ConstructionIntelligent SystemsManufacturing
Series ADec 13, 2024
Amount Raised: $12,369,264
Affinity

Pudong, Shandong, China

Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.

BiopharmaBiotechnologyPharmaceutical
Series BDec 2, 2024
Amount Raised: $55,007,770
Mingyuan Ecology

Xuanhan, Sichuan, China

Mingyuan Ecology focuses on developing health care agriculture and integrating healthy agricultural practices.

AgricultureAgTechForestry
Series ASep 4, 2024
Sineva

Hefei, Anhui, China

Sineva engages in R&D, manufacturing and sales of transfer robots, test robots, service robots and intelligent factory solutions.

ManufacturingRoboticsSales
Series ASep 1, 2021
Amount Raised: $92,879,257